1-2 of 2
Authors: Vincent Meiffredy
Journal Article
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 9, September 2022, Pages 2506–2515, https://doi.org/10.1093/jac/dkac207
Published: 28 June 2022
Journal Article
HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 3, March 2022, Pages 735–739, https://doi.org/10.1093/jac/dkab427
Published: 23 November 2021
